Thursday, September 1, 2022

Fetterman rejects Oz offer to hold first debate, calls list of 'concessions' insulting



from Yahoo News - Latest News & Headlines https://ift.tt/1Gwvd7X

No comments:

Post a Comment

FDA clears IND for clinical trial testing switchable CAR-T therapy in patients with autoimmune diseases, without chemotherapy

FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001...